EKMAN LARS sold 98.5% of their position (15.83K shares) of PROTHENA CORP PUBLIC LTD CO on the open market
Open‑market sale worth $975.4K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/2/2022ACC: 0001140361-22-044319
DirectorOther
Since May 2019
-15.83K
Net shares
Net seller
$975.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
15.83K acquired · 31.67K disposed
Non-Derivative Transactions3
Ordinary Shares, par value $0.01 per share
Direct
Shares
+15.83K
Price / share
$6.41
Trade value
$101.50K
% of position
6516.0%
12/1/2022
243.00→16.08K
Ordinary Shares, par value $0.01 per share
Direct
Shares
−9.81K
Price / share
$61.28
Trade value
$601.39K
% of position
61.0%
12/1/2022
16.08K→6.26K
Ordinary Shares, par value $0.01 per share
Direct
Shares
−6.02K
Price / share
$62.12
Trade value
$374.02K
% of position
96.1%
12/1/2022
6.26K→243.00
Total
Net shares
+0.00
Net value
-$873.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.01 per share Direct | 12/1/2022 | M · Option Exercise | +15.83K | $6.41 | $101.50K | 6516.0% | 243.00 | 16.08K |
| Ordinary Shares, par value $0.01 per share Direct | 12/1/2022 | S · Sale | −9.81K | $61.28 | $601.39K | 61.0% | 16.08K | 6.26K |
| Ordinary Shares, par value $0.01 per share Direct | 12/1/2022 | S · Sale | −6.02K | $62.12 | $374.02K | 96.1% | 6.26K | 243.00 |
| Total | +0.00 | -$873.91K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Ordinary Shares
15.83K shares
Shares
−15.83K
Strike price
6.41
Held after
15.83K
Exercisable
—
12/1/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Ordinary Shares15.83K shares | 12/1/2022 | M · Option Exercise | −15.83K | 6.41 | — | 15.83K |